Clinical Trials Directory

Trials / Completed

CompletedNCT04094545

Intestinal Flora Sequencing for Nasopharyngeal Carcinoma

Intestinal Flora Disruption and a Novel Intestinal Biomarker Associated With Nasopharyngeal Carcinoma

Status
Completed
Phase
Study type
Observational
Enrollment
568 (actual)
Sponsor
The Third Xiangya Hospital of Central South University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study investigated the correlation between the changes in the intestinal flora and NPC by an examination of the intestinal flora and multiple clinical indicators of the blood of 8 carefully screened patients of familial NPC, 24 patients of sporadic NPC and 27 healthy controls and a comparison of the differences in their intestinal flora structures and biological functions. By analyzing the function of the intestinal floras of NPC patients, we aimed to provide a better biological marker for patients with familial and sporadic NPC and constructed a disease prediction model for high-risk populations.

Detailed description

Nasopharyngeal carcinoma (NPC) is a malignant nasopharyngeal disease with a complicated etiology that occurs mostly in southern China. Intestinal flora imbalance is believed to be associated with a variety of organ malignancies. Currently, the relationship between intestinal flora and NPC is not clear, although many studies have shown that intestinal flora can be used as a biomarker for many cancers and to predict cancer. To compare the differences in intestinal flora compositions and biological functions among patients with familial NPC (NPC\_F), patients with sporadic NPC (NPC\_S) and healthy controls (NOR), we compared the intestinal flora DNA sequencing and hematological testing results between every two groups using bioinformatic methods.

Conditions

Timeline

Start date
2018-08-01
Primary completion
2018-12-31
Completion
2019-05-30
First posted
2019-09-19
Last updated
2019-09-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04094545. Inclusion in this directory is not an endorsement.